Aummune develops a first-of-its-kind individual drug-customization platform that utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional aptamer drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses
| Website | http://www.aummune.com |
| Employees | 13 (13 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research, Business Services General, Therapeutics, Other Pharmaceuticals and Biotechnology, Business Services, Health Care |
| Keywords | Cancer Treatment, Therapeutics, Personalized Medicine, Aptamer Therapeutics, Immunotherapy, Targeted Therapy, Cancer Research, Oncology, Biotechnology, Pharmaceutical, Drug Development, Precision Medicine, Genetic Testing, Clinical Trials, Healthcare, Medical Technology, Biopharma |
| Competitors | Johnson & Johnson, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Regeneron, Moderna Therapeutics, Novavax, Pfizer, CureVac +35 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies |
Looking for a particular Aummune employee's phone or email?
Erez Lavi is the Director of Personalized Medicine of Aummune.
13 people are employed at Aummune.
Aummune is based in Tel Aviv, Tel Aviv.
The NAICS codes for Aummune are [54171, 541, 54, 541713, 5417].
The SIC codes for Aummune are [87, 873].